Page 52 - GTM-3-1

Global Translational Medicine Personalized, multi-omics disease detection

doi: 10.1038/s41587-021-01145-6 doi: 10.1038/s41528-021-00107-x
42. Smith AA, Li R, Tse ZTH. Reshaping healthcare with 53. Özsoylu D, Janus KA, Achtsnicht S, Wagner T, Keusgen M,
wearable biosensors. Sci Rep. 2023;13(1):4998. Schöning MJ. (Bio-)Sensors for skin grafts and skin flaps
monitoring. Sens Actuators Rep. 2023;6:100163.
doi: 10.1038/s41598-022-26951-z
doi: 10.1016/j.snr.2023.100163
43. Huhn S, Axt M, Gunga HC, et al. The impact of wearable
technologies in health research: Scoping review. JMIR 54. (FDA) USFaDA. Artificial Intelligence and Machine Learning
Mhealth Uhealth. 2022;10(1):e34384. (AI/ML)-Enabled Medical Devices. Available from: https://
www.fda.gov/medical-devices/software-medical-device-
doi: 10.2196/34384
samd/artificial-intelligence-and-machine-learning-aiml-
44. Lu L, Zhang J, Xie Y, et al. Wearable health devices in health enabled-medical-devices [Last accessed on 2023 Nov 30].
care: Narrative systematic review. JMIR Mhealth Uhealth.
2020;8(11):e18907. 55. Peters DM, O’Brien ES, Kamrud KE, et al. Utilization of
wearable technology to assess gait and mobility post-stroke:
doi: 10.2196/18907 A systematic review. J Neuroeng Rehabil. 2021;18(1):67.
45. Wells CI, Xu W, Penfold JA, et al. Wearable devices to doi: 10.1186/s12984-021-00863-x
monitor recovery after abdominal surgery: Scoping review.
BJS Open. 2022;6(2):zrac031. 56. Daskalaki E, Parkinson A, Brew-Sam N, et al. The potential of
current noninvasive wearable technology for the monitoring
doi: 10.1093/bjsopen/zrac031 of physiological signals in the management of type 1 diabetes:
46. Horsham C, Antrobus J, Olsen CM, Ford H, Abernethy D, Literature survey. J Med Internet Res. 2022;24(4):e28901.
Hacker E. Testing wearable UV Sensors to improve sun doi: 10.2196/28901
protection in young adults at an outdoor festival: Field study.
JMIR Mhealth Uhealth. 2020;8(9):e21243. 57. Smarr BL, Aschbacher K, Fisher SM, et al. Feasibility of
continuous fever monitoring using wearable devices. Sci
doi: 10.2196/21243 Rep. 2020;10(1):21640.
47. Salusky IB, Holloway M, Kuizon BD. Peritoneal dialysis doi: 10.1038/s41598-020-78355-6
in children: Issues for the 21 century. Perit Dial Int. rd
st
1999;19(Suppl 2):S484-S488. 58. Gilliam FR, 3 , Ciesielski R, Shahinyan K, et al. In-ear
infrasonic hemodynography with a digital health device for
48. Al Younis SM, Hadjileontiadis LJ, Stefanini C, Khandoker cardiovascular monitoring using the human audiome. NPJ
AH. Non-invasive technologies for heart failure, systolic Digit Med. 2022;5(1):189.
and diastolic dysfunction modeling: A scoping review. Front
Bioeng Biotechnol. 2023;11:1261022. doi: 10.1038/s41746-022-00725-3
59. Cheng CH, Wong KL, Chin JW, Chan TT, So RHY. Deep
doi: 10.3389/fbioe.2023.1261022
learning methods for remote heart rate measurement: A review
49. Prieto-Avalos G, Cruz-Ramos NA, Alor-Hernandez G, and future research agenda. Sensors (Basel). 2021;21(18):6296.
Sanchez-Cervantes JL, Rodriguez-Mazahua L, Guarneros-
Nolasco LR. Wearable devices for physical monitoring of doi: 10.3390/s21186296
heart: A review. Biosensors (Basel). 2022;12(5):292. 60. Sadad T, Bukhari SAC, Munir A, Ghani A, El-Sherbeeny AM,
Rauf HT. Detection of cardiovascular disease based on ppg
doi: 10.3390/bios12050292
signals using machine learning with cloud computing.
50. Handy C, Chaudhry MS, Qureshi MRA, et al. Noninvasive Comput Intell Neurosci. 2022;2022:1672677.
continuous glucose monitoring with a novel wearable
dial resonating sensor: A clinical proof-of-concept study. doi: 10.1155/2022/1672677
J Diabetes Sci Technol. 2023. 61. Heiden E, Jones T, Brogaard Maczka A, et al. Measurement
of vital signs using lifelight remote photoplethysmography:
doi: 10.1177/19322968231170242
Results of the VISION-D and VISION-V observational
51. Van de Hei SJ, Poot CC, van den Berg LN, et al. Effectiveness, studies. JMIR Form Res. 2022;6(11):e36340.
usability and acceptability of a smart inhaler programme in
patients with asthma: Protocol of the multicentre, pragmatic, doi: 10.2196/36340
open-label, cluster randomised controlled ACCEPTANCE 62. Saboo B, Kesavadev J, Shankar A, et al. Time-in-range as a target
trial. BMJ Open Respir Res. 2022;9(1):e001400. in type 2 diabetes: An urgent need. Heliyon. 2021;7(1):e05967.
doi:10.1136/bmjresp-2022-001400 doi: 10.1016/j.heliyon.2021.e05967
52. Iqbal SMA, Mahgoub I, Du E, Leavitt MA, Asghar W. 63. Zou Y, Chu Z, Guo J, Liu S, Ma X, Guo J. Minimally invasive
Advances in healthcare wearable devices. NPJ Flex Electron. electrochemical continuous glucose monitoring sensors: Recent
2021;5(1):9. progress and perspective. Biosens Bioelectron. 2023;225:115103.

Volume 3 Issue 1 (2024) 12 https://doi.org/10.36922/gtm.2357